Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure (Q80312829)
Jump to navigation
Jump to search
scientific article published on 21 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure |
scientific article published on 21 September 2006 |
Statements
Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure (English)
Alfonso Quintas-Cardama
Hagop Kantarjian
Dan Jones
Claude Nicaise
Susan O'Brien
Francis Giles
Moshe Talpaz
Jorge Cortes
21 September 2006